Rapidly changing cannabis legalization has contributed to increased cannabis use and co-use of cannabis and alcohol, including among sexual and gender minori…
Cannabis Use Is Associated With Increased Healthcare Utilization and Poorer Outcomes in Cyclical Vomiting Syndrome-A Propensity Matched Analysis of 34,988 Individuals.
Cyclical Vomiting Syndrome (CVS) poses a significant financial burden on the healthcare system due to frequent emergency department (ED) visits and hospitali…
Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis.
The authors compared the risk of mental disorders between patients with cannabis use disorder (CUD) and those with other substance use disorders (SUDs). The …
Relationship of Ethanol, Cannabinoids, Benzodiazepines, and Opioids to Serious Injuries from Falls in Adults Aged 55 and Older.
Falls among adults aged 55 and older lead to significant morbidity and mortality. The contribution of alcohol and other sedating drugs (including benzodiazep…
Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV.
We explored whether self-reported current cannabis use is associated with inflammatory biomarkers among people with HIV (PWH), given high rates of cannabis u…
The relationship between maternal cannabis use disorder diagnosis and the development of retinopathy of prematurity.
To compare the incidence of retinopathy of prematurity (ROP) among preterm infants born to mothers with and without a cannabis use disorder (CUD) diagnosis. …
Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain.
Medical cannabis is increasingly considered a substitute for prescription opioid medications for chronic pain, driven by the urgent need for opioid alternati…
Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States.
Cannabinoid Hyperemesis Syndrome (CHS) is an emerging condition among those with heavy cannabis use characterized by persistent and severe nausea and vomitin…
Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration.
Cannabidiol (CBD) and cannabigerol (CBG) are non-psychoactive phytocannabinoids with emerging therapeutic potential in metabolic dysfunction-associated steat…
Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.
Evidence for medical cannabis use and effectiveness in autism has begun to accumulate but remains limited, even as clinical interest has rapidly increased. I…